Alight (ALIT) Q4 2025 earnings review
Massive Impairments and Dividend Cut Define a Shrinking Quarter
Alight finished FY25 on a somber note. Fourth-quarter revenue fell 4.0% YoY to $653M, confirming the business is shrinking rather than growing. The bottom line was decimated by an $803M non-cash goodwill impairment charge—bringing the full-year impairment total to over $3.1B—signaling a fundamental reassessment of the company's value. Adjusted EBITDA fell 18% YoY to $178M. In a major capital allocation pivot, management suspended the quarterly dividend to focus on deleveraging and share buybacks.
🐂 Bull Case
Despite top-line pressure, 93% of revenue remains recurring. This provides a floor for cash flow even as project work evaporates.
Selling, General, and Administrative expenses decreased by $37M YoY, driven by productivity savings and lower professional fees. Management is effectively cutting costs to match the shrinking revenue profile.
🐻 Bear Case
Revenue declined 4% YoY in Q4 and 3% for the full year. The 'transformation' story is not translating into top-line expansion, with lower net commercial activity and project revenue weighing on results.
The company recorded a staggering $3.1B in goodwill impairments for FY25 ($803M in Q4 alone). This is a massive admission that the business is worth significantly less than carried on the balance sheet.
⚖️ Verdict: 🔴🔴
Bearish. A 4% revenue decline, elimination of the dividend, and billions in write-downs paint a picture of a company in distress, not transformation. The pivot to buybacks over dividends suggests an attempt to engineer EPS support amidst operational weakness.
Key Themes
Capital Allocation Pivot: Dividend Suspended
Alight announced it will replace its cash dividend with 'more efficient capital allocation activities,' specifically deleveraging and share repurchases. While buybacks can be accretive, suspending a dividend often signals cash flow prioritization concerns or a desperate need to support the stock price.
Goodwill Impairment Spiral
The company took another $803M goodwill impairment in Q4, following massive charges earlier in the year ($3.1B total FY25). This non-cash charge wipes out equity value and reflects management's acknowledgment of 'current business trends' and a depressed market valuation.
Commercial Activity Slowdown
Revenue decreased 4.0% driven by 'lower project revenue and lower net commercial activity.' This continues a trend of deceleration seen throughout FY25. The inability to offset project revenue declines with new commercial wins is a structural weakness.
Cost Structure Improvement
SG&A expenses dropped $37M YoY. The company is successfully executing on productivity savings and reducing stock-based compensation, which is crucial for protecting margins in a declining revenue environment.
AI Integration
Management highlighted a 'favorable response' to a piloted conversational AI assist agent. While currently a narrative point, successful scaling of AI in benefits administration is critical for long-term margin defense.
Other KPIs
Decelerating. Down 18% from $217M in 24Q4. Margin compressed to 27.3% from 31.9% a year ago. The leverage from cost cuts was insufficient to offset the drop in high-margin project revenue.
Stable. FY25 Free Cash Flow was $250M compared to $72M in FY24 (note: FY24 comparability is affected by discontinued ops noise). Operating cash flow was strong at $360M, showing the business still generates cash despite GAAP losses.
Improving. Total debt net of cash is $1.73B, down from $2.8B+ levels in prior years (aided by divestitures). Further deleveraging remains a capital allocation priority replacing the dividend.
Guidance
Reversing. The company explicitly announced the replacement of its cash dividend with share repurchases and balance sheet deleveraging. This marks an immediate cessation of income for yield-focused investors.
Management believes share repurchases at current price levels are a 'more effective mechanism' than dividends. This implies management views the stock as significantly undervalued following the impairment-driven selloff.
Key Questions
Impairment Runway
With over $3 billion in impairments in FY25, is the book value now fully reset, or is there further downside risk to the remaining $83M in Goodwill and $2.5B in Intangibles?
Commercial Turnaround
Revenue has declined for consecutive quarters due to 'lower net commercial activity.' What specific leading indicators (bookings, backlog) suggest a return to growth in FY26?
Project Revenue Visibility
Project revenue continues to be a drag on results. Is this a cyclical downturn in the industry or a structural shift away from discretionary benefits projects?
Buyback Aggression
With the dividend cut, how aggressive will the share repurchase program be in Q1/Q2 2026? Will you utilize the full authorization immediately given the 'undervalued' commentary?